Transactions
Deal Showcase
$125 Million
Joint Bookrunner
Follow-On
February 2023
More Transactions
$119 Million
Joint Bookrunner
Follow-On
October 2021
$150 Million
Joint Bookrunner
Follow-On
December 2023
$35 Million
Exclusive Financial Advisor
Series C Financing Led by MultiPlan Corporation
June 2022
Featured Insights
Podcasts
February 2025
Managing Director of Pharmagellan and Professor of the Practice at Tufts University, Frank S. David, MD, PhD
Articles
February 2025
Why Yorvipath® is a Good Deal for Society
Featured Research
February 2025
Landscape of Multi-Targeted Bispecifics in I&I
